Eric Schuur is an experienced professional who has held various leadership roles in the biotechnology and medical field. With a PhD in Experimental Pathology from UCLA, Eric has served as the Chief Executive Officer and President of multiple companies, including GeneSource, Inc. and HepaTx Corporation. Eric also has experience in clinical development, data analysis, and research, having worked at companies like Asthmatx, Inc. and Stanford University. Currently, Eric is involved in various organizations and serves as a consultant at BioIntel Consulting. Additionally, Eric is the Director at StartX Med Labs Cooperative Inc. and is actively involved in advancing therapy manufacturing standards at ARMI.
This person is not in any offices
ISCT, International Society for Cell & Gene Therapy
ISCT is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients.